Literature DB >> 2013297

Uptake and isomerization of all-trans retinol by isolated bovine retinal pigment epithelial cells: further clues to the visual cycle.

A M Timmers1, D A van Groningen-Luyben, W J de Grip.   

Abstract

The site and substrate for all-trans to 11-cis isomerization in the visual cycle have remained obscure for several decades. Only recently studies on a subcellular level have begun to shed some light on these phenomena. We have addressed this system on a cellular level by utilizing intact isolated bovine retinal pigment epithelial cells, maintained during short-term incubation in vitro. Supplementation with labeled all-trans retinol incorporated in a lipid vesicle carrier, in a range of 1-6 nmol per 10(6) cells, resulted in a rapid uptake of retinol. The majority of the internalized retinol was processed prior to mixing with endogenous retinoid pools and most of it was converted into all-trans retinylester. Up to 10% of the incorporated label was isomerized yielding 11-cis retinol, 11-cis retinaldehyde and 11-cis retinylester. The kinetics of the 11-cis retinoid formation indicated that 11-cis retinol is the first isomerization product. The level of 11-cis retinol apparently 'triggered' further processing into other 11-cis retinoids. An updated model with discussion topics is presented for the retinoid pathway relevant to the visual cycle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013297     DOI: 10.1016/0014-4835(91)90253-b

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

Review 1.  The cone-specific visual cycle.

Authors:  Jin-Shan Wang; Vladimir J Kefalov
Journal:  Prog Retin Eye Res       Date:  2010-11-25       Impact factor: 21.198

Review 2.  Interphotoreceptor retinoid-binding protein (IRBP). Molecular biology and physiological role in the visual cycle of rhodopsin.

Authors:  D R Pepperberg; T L Okajima; B Wiggert; H Ripps; R K Crouch; G J Chader
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.